See more : Aerojet Rocketdyne Holdings, Inc. (AJRD) Income Statement Analysis – Financial Results
Complete financial analysis of KP Tissue Inc. (KPTSF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of KP Tissue Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Aegis Logistics Limited (AEGISCHEM.NS) Income Statement Analysis – Financial Results
- COFCO Biotechnology Co., Ltd. (000930.SZ) Income Statement Analysis – Financial Results
- Etruscus Resources Corp. (ETRUF) Income Statement Analysis – Financial Results
- DICE Therapeutics, Inc. (DICE) Income Statement Analysis – Financial Results
- Bharat Electronics Limited (BEL.NS) Income Statement Analysis – Financial Results
KP Tissue Inc. (KPTSF)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.kptissueinc.com
About KP Tissue Inc.
KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins, as well as manufactures private label tissue products. The company markets its products under the Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, White Swan, and Metro brand names. The company sells its products to consumers through traditional retail channels, such as grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers; and through distributors to businesses involved in commercial users in the property management, healthcare, food services, manufacturing, lodging industries, and public facilities. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 830.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | -752.00K | -321.00K | -634.00K | 574.00K | 196.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 830.00K | -752.00K | -321.00K | -634.00K | 574.00K | 196.00K | 3.25M | 67.00K | 33.41M | 2.28M | 1.73M | 3.96K |
| Cost & Expenses | 830.00K | -752.00K | -321.00K | -634.00K | 574.00K | 196.00K | 3.25M | 67.00K | 33.41M | 2.28M | 1.73M | -3.96K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 11.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 238.61K | 115.99M | 153.43M | 197.84M | 145.04M | 161.14K | 52.52K | 22.82K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 238.61K | 115.99M | 153.43M | 197.84M | 145.04M | 0.00 | 0.00 | 0.00 | -33.41M | -2.28M | 1.73M | -2.77K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Operating Income | 0.00 | -752.00K | -321.00K | -634.00K | -574.00K | -196.00K | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | -2.77K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Total Other Income/Expenses | -830.00K | -12.55M | 1.12M | -794.00K | -4.23M | 1.78M | 0.00 | 67.00K | 33.41M | 0.00 | 1.73M | -3.96K |
| Income Before Tax | -830.00K | -12.55M | 1.12M | -794.00K | -4.80M | 1.59M | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | -3.96K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Income Tax Expense | 4.11M | -2.30M | -118.00K | 1.16M | 1.73M | 1.76M | 2.19M | 1.79M | -2.07M | 241.00K | 2.01M | 592.00 |
| Net Income | -4.94K | -10.25M | 1.24M | -1.95M | -6.53M | -173.00K | -5.44M | -1.72M | -31.34M | -2.52M | -285.00K | -3.36K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 167.42% | -2,570.15% | 93.82% | 110.58% | -16.49% | 0.00% |
| EPS | -0.50 | -1.03 | 0.13 | -0.20 | -0.68 | -0.02 | -0.59 | -0.19 | -3.52 | -0.29 | -0.03 | 0.00 |
| EPS Diluted | -0.50 | -1.03 | 0.13 | -0.20 | -0.68 | -0.02 | -0.59 | -0.19 | -3.52 | -0.29 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 9.96M | 9.94M | 9.84M | 9.70M | 9.54M | 9.32M | 9.16M | 9.04M | 8.91M | 8.83M | 8.75M | 8.00M |
| Weighted Avg Shares Out (Dil) | 9.96M | 9.94M | 9.84M | 9.70M | 9.54M | 9.32M | 9.16M | 9.04M | 8.91M | 8.83M | 8.75M | 8.00M |
KP Tissue Releases Fourth Quarter and Full Year 2023 Financial Results
KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Fourth Quarter of 2023
KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Fourth Quarter of 2023
KP Tissue announces retirement of CFO Mark Holbrook and Appointment of Michael Keays
KP Tissue Inc. (KPTSF) Q3 2023 Earnings Call Transcript
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
KP Tissue Releases Third Quarter 2023 Financial Results
REMINDER: KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Third Quarter of 2023
KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Third Quarter of 2023
KP Tissue Inc. (KPTSF) Q2 2023 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports